D'ADAMO, MARIA CRISTINA 
 Distribuzione geografica
Continente #
NA - Nord America 1.665
EU - Europa 443
AS - Asia 367
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 2.485
Nazione #
US - Stati Uniti d'America 1.659
SG - Singapore 305
FI - Finlandia 170
DE - Germania 137
IT - Italia 39
CN - Cina 33
BE - Belgio 25
CZ - Repubblica Ceca 21
HK - Hong Kong 15
EE - Estonia 11
NL - Olanda 8
FR - Francia 7
SA - Arabia Saudita 6
CA - Canada 5
GB - Regno Unito 5
AU - Australia 4
RU - Federazione Russa 4
AT - Austria 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
ES - Italia 2
IL - Israele 2
IN - India 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
ID - Indonesia 1
MX - Messico 1
NO - Norvegia 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 2.485
Città #
Chandler 580
Helsinki 170
Singapore 130
Ashburn 114
Lawrence 107
Princeton 107
Munich 91
Las Vegas 44
Hanover 39
Brussels 25
Boardman 23
Brno 20
Miami 16
Hong Kong 15
Seattle 10
Genoa 9
Atlanta 7
Shanghai 4
Milan 3
Paris 3
Toronto 3
Varese 3
Andover 2
Bologna 2
Cambridge 2
Guangzhou 2
Los Angeles 2
Madrid 2
Nanyang 2
New York 2
Novokuznetsk 2
Perugia 2
Piscataway 2
Riyadh 2
Roubaix 2
Weston-super-Mare 2
Zhengzhou 2
Al Ain City 1
Amsterdam 1
Augusta 1
Baku 1
Beijing 1
Belgrade 1
Buffalo 1
Clifton 1
Cupertino 1
Den Haag 1
Dunedin 1
Florence 1
Hamm 1
Hangzhou 1
Harbin 1
Iesi 1
Jiangmen 1
Lanzhou 1
Mexico City 1
Mumbai 1
Nanchang 1
Nanning 1
Ningde 1
Olomouc 1
Qinhuangdao 1
Quito 1
Raanana 1
Richmond 1
Rizhao 1
Rome 1
Santa Clara 1
Siena 1
Sofia 1
Stockholm 1
Suri 1
Sydney 1
Tashkent 1
Tel Aviv 1
The Dalles 1
Trumbull 1
Vergiate 1
Weihai 1
Zurich 1
Totale 1.596
Nome #
A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine 80
Altered functional properties of a missense variant in the TRESK K+ channel (KCNK18) associated with migraine and intellectual disability 68
Clinical and Functional Study of a De Novo Variant in the PVP Motif of Kv1.1 Channel Associated with Epilepsy, Developmental Delay and Ataxia 65
A novel KCNA1 mutation in a patient with paroxysmal ataxia, myokymia, painful contractures and metabolic dysfunctions 62
Association of A Novel Splice Site Mutation in P/Q-Type Calcium Channels with Childhood Epilepsy and Late-Onset Slowly Progressive Non-Episodic Cerebellar Ataxia 61
Adrenergic Stimulation of Tissue-type Plasminogen Activator Release in a Model of Vascular Perfusion in Rats 35
A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia 34
Identification of a New de Novo Mutation Underlying Regressive Episodic Ataxia Type I 33
Fotorecettori ed Epitelio Pigmentato della Retina; Meccanismi di Trasduzione e Rinnovamento 31
Differential pH-sensitivity of Kir4.1 and Kir4.2 and modulation by heteropolymerisation with Kir5.1 31
Lethal digenic mutations in the K+channels kir4.1 (KCNJ10) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay 30
Localization and Age Dependent Expression of the Inward Rectifier K+ Channel Kir 5.1 in a Mammalian Reproductive System 30
5-HT2 receptors-mediated modulation of voltage-gated K+ channels and neurophysiopathological correlates 30
Genetic inactivation of Kcnj16 identifies Kir5.1 as an important determinant of neuronal PCO2/pH sensitivity 30
Reconciling the discrepancies on the involvement of large-conductance Ca(2+)-activated K channels in glioblastoma cell migration 29
De novo point mutations in patients diagnosed with ataxic cerebral palsy 29
A method to identify tissue cell subpopulations with distinct multi-molecular profiles from data on co-localization of two markers at a time: the case of sensory ganglia 29
Effect of Aspirin on the Fibrinolytic Response in Perfused Rat Hindquarters 29
The Episodic Ataxia Type 1 Mutation F184C Alters the Zn2+ Modulation of the Human Kv1.4-Kv1.1/Kvbeta1 Channel 28
Amiloride Inhibits Tissue-Type Plasminogen Activator (t-PA) Release from Vascular Endothelium 28
Autism with Seizures and Intellectual Disability: Possible Causative Role of Gain-of-Function of the Inwardly-Rectifying K+ Channel Kir4.1 28
Dexamethasone in Glioblastoma Multiforme Therapy: Mechanisms and Controversies 28
Episodic ataxia type 1 mutations cause loss-of-function impairments of heteromeric channels formed by the Kv1.4 and Kv1.1 subunits 28
Genetic investigation of children with ataxia using exome sequencing 27
Murine Models of EA1 27
Publisher Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 27
Kcnj16 (Kir5.1) Gene Ablation Causes Subfertility and Increases the Prevalence of Morphologically Abnormal Spermatozoa 27
Mutations in KCNA1 affect stoichiometry and fast inactivation of heteromeric K+ channels 26
A Calsequestrin-1 mutation associated with a skeletal muscle disease alters sarcoplasmic Ca2+ release 26
Animal Models of Episodic Ataxia Type 1 (EA1) 25
Hypercoagulable State in Aged Rats 25
Different Response of Vascular Fibrinolysis to Adrenergic Stimulation in Young and Aged Rats 25
Genetically-induced abnormalities of Kir2.1 channels: implications for short QT3 syndrome and autism/epilepsy phenotype 25
Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder 25
A Novel KCNA1 Mutation Identified in an Italian Family Affected by Episodic Ataxia Type 1 25
Author Correction: Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 25
Antithrombotic Activity of Dermatan Sulphates, Heparin and their Combination in an Animal Model of Arterial Thrombosis 25
An Episodic Ataxia Type-1 (EA1) mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+ 25
Gain-of-function defects of astrocytic Kir4.1 channels in children with autism spectrum disorders and epilepsy 25
Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene 25
Copertina della rivista scientifica: Neuroscience 24
ERG channels regulate the excitability of medial vestibular neurons 24
Role of RPTPα and Tyrosine Phosphorylation in the Serotonergic Inhibition of Voltage-Dependent Potassium Channels 24
The emerging role of the inwardly rectifying K+channels in autism spectrum disorders andepilepsy 24
KCNK18 Biallelic Variants Associated with Intellectual Disability and Neurodevelopmental Disorders Alter TRESK Channel Activity 24
Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in KCNA1 Impairing the Voltage Sensitivity of Kv1.1 Channel 24
The Episodic Ataxia Type 1 Mutation F184C Alters the Zn2+ Modulation of the Human Kv1.4-Kv1.1/Kvbeta1 Channel 23
Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis 23
Episodic Ataxia Type 1 Mutations Affect Fast Inactivation of K+ Channels by a Reduction in Either Subunit Surface Expression or Affinity for Inactivation Domain 23
Electromechanical coupling of the Kv1.1 voltage-gated K+ channel is fine-tuned by the simplest amino acid residue in the S4-S5 linker 23
The neurobiology of episodic ataxia type 1: a Shaker-like K+ channel disorder 22
Thrombotic Tendency in Spontaneously Hypercholesterolemic Rats 22
Identification and functional characterization of a novel mutation in the KCNA1 gene of a Sicilian family affected by episodic ataxia type 1 22
Changes in Primary Hemostasis During Thrombus Formation in a Model of Artherial Thrombosis in Rats 22
Differential pH-sensitivity of Kir4.1 and Kir4.2 and Modulation by Heteropolymerisation with Kir5.1. 22
Changes in Primary Hemostasis and Blood Coagulation During the Formation of an Arterial Thrombus in Rats 22
The Response of Vascular Fibrinolysis to the Adrenergic Stimulation is Abnormal in Aged Rats 22
Episodic Ataxia Type 1 Mutations in the KCNA1 Gene Impair the Fast Inactivation Properties of the Human K+ Channels Kv1.4-1.1/Kvbeta1.1 and Kv1.4-1.1/Kvbeta1.2. 22
KCNA4 deficiency leads to a syndrome of abnormal striatum, congenital cataract and intellectual disability 22
Episodic Ataxia Type 1 Mutation F184C Alters Zn2+-Induced Modulation of the Human Potassium Channel Kv1.4-Kv1.1/Kvbeta1.1 22
Role of the vascular wall in the thrombotic Tendency of Hypercholesterolemic Rats 21
Contributions of the central hydrophobic residue in the PXP motif of Voltage-Dependent K+ Channels to S6 flexibility and Gating Properties 21
Changes of the Hemostatic Balance in a Model of Aging in Rats 21
Mutations in the KCNA1 Gene Associated with Episodic Ataxia Type-1 Syndrome Impair Heteromeric Voltage-Gated K+ Channel Function 21
The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma 21
Neutrophil Derived Cathepsin G Induce Potentially Thrombogenic Changes in Human Endothelial Cells: a scanning electron microscopy study in static and dynamic conditions 21
Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature 21
Abnormal Vascular Response to Fibrinolytic Stimulation inAged Rats 21
Electromechanical coupling of the Kv1.1 voltage-gated K+ channel is fine-tuned by the simplest amino acid residue in the S4-S5 linker 21
The CaMKII/MLC1 Axis Confers Ca2+-Dependence to Volume-Regulated Anion Channels (VRAC) in Astrocytes 20
The Role of alfa-adrenergic Receptors in the Acute Release of Tissue-Type Plasminogen Activator (t-PA) in a Model of Vascular Perfusion in Rats 20
Role of inwardly-rectifying potassium channels Kir5.1 in learning and memory processes in a mouse knock-out model 20
Cardiac Structural Alteration and Thrombotic Tendency in Spontaneously Hypercholestreolemic Rat 20
Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation 20
New insights into the pathogenesis and therapeutics of episodic ataxia type 1 20
Commentary: A channelopathy mutation in the voltage-sensor discloses contributions of a conserved phenylalanine to gating properties of Kv1.1 channels and ataxia 20
Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches 20
Episodic ataxia type-1 mutations in the hKv1.1 citoplasmic pore region alter the gating properties of the channels. 19
Morphological and Homeostatic Changes in Rats with Abdominal Arterial Prosthesis 19
Expression in e.coli and purification of recombinant fragments of wild type and mutant human prion protein 19
Functional Characterization of an Episodic Ataxia Type-1 Mutation Occurring in the S1 Segment of hKv1.1 Channels. 19
pH-Dependence of the Inwardly Rectifying Potassium Channel Kir5.1 and Localisation in Renal Tubular Epithelia 19
Gain-of-Function of the Inwardly-Rectifying K+ Channel Kir4.1 Contributes to Autism with Seizures and Intellectual Disability 19
Cathepsin G, a Polymorphonuclear Leucocyte Protease, Affects Endothelial Monolayer Integrity Both in Vivo and ex Vivo 18
Vascular Fibrinolysis in Aging: Enhanced Response to Adrenergic Stimulation 18
Episodic Ataxia Type 1 18
Modulation of delayed rectifier K+ channels by 5HT2c receptors 18
Ion Channels Involvement in Neurodevelopmental Disorders 18
Copertina della rivista The Journal of Physiology 17
ERG channels modulate the medial vestibular neurons processing of temporal information 17
Role of the S1 segment in the voltage-dependent gating of Kv1.1 channels revealed by naturally occurring pathogenic mutations. 17
Mutations in KCNA1 gene associated with episodic ataxia type-1 sindrome impair heteromeric voltage-gated K+ channel function 17
Identification of a heteromeric interaction which influences the rectification, gating and pH-sensitivity of Kir4.1/Kir5.1 potassium channels 17
Episodic Ataxias as Ion Channel Diseases 15
Gating properties of human heteromeric voltage-gated potassium channels and effects of episodic ataxia type-1 mutations. 15
null 13
Voltage-gated calcium channels modulate synaptic transmission at vestibular neurons 12
Modulation of hKv 1.1 and hKv 1.2 voltage gating and C-type inactivation by 5-HT2C receptors 11
Functional Properties of Voltage-Gated Potassium Channels Probed with Methanethiosulfonate Reagents. 11
Effects of Episodic Ataxia-Associated Mutations on hKv1.4-1.1/Kvbeta1 channels 11
Totale 2.493
Categoria #
all - tutte 44.301
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.301


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022181 0 0 0 0 0 0 96 16 28 31 4 6
2022/20231.360 218 25 4 218 152 235 2 101 214 63 123 5
2023/2024483 33 79 34 29 96 79 10 1 72 7 0 43
2024/2025624 18 15 15 165 110 70 12 19 189 11 0 0
Totale 2.648